financetom
Business
financetom
/
Business
/
--Bausch Health Refutes Earlier Claim by Reorg of Bankruptcy
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
--Bausch Health Refutes Earlier Claim by Reorg of Bankruptcy
Jul 24, 2024 10:27 AM

01:06 PM EDT, 07/24/2024 (MT Newswires) --

Price: 5.94, Change: -1.64, Percent Change: -21.60

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Duke Energy receives approval to extend operations at Oconee nuclear plant
Duke Energy receives approval to extend operations at Oconee nuclear plant
Mar 31, 2025
March 31 (Reuters) - U.S. utility Duke Energy ( DUK ) said on Monday the Nuclear Regulatory Commission (NRC) has approved the license renewal of its Oconee nuclear station in South Carolina for another 20 years. The U.S. nuclear industry has garnered renewed interest in recent times after decades of stagnation, supported by a surge in power demand propelled by...
LifeSpeak Posts Wider Fourth-quarter, Lower Revenue
LifeSpeak Posts Wider Fourth-quarter, Lower Revenue
Mar 31, 2025
05:31 PM EDT, 03/31/2025 (MT Newswires) -- LifeSpeak ( LSPKF ) after trade Monday said its fourth-quarter loss widened slightly as revenue fell year-over-year. The company reported adjusted loss. excluding most one-time items of $2.58 million, or $0.04 per share, in the period, compared with a loss of $2.36 million, or $0.05, a year ago. FactSet expected a loss of...
US FDA approves freeze-dried version of Bavarian Nordic's mpox, smallpox vaccine
US FDA approves freeze-dried version of Bavarian Nordic's mpox, smallpox vaccine
Mar 31, 2025
March 31 (Reuters) - Denmark's Bavarian Nordic ( BVNKF ) said on Monday the U.S. Food and Drug Administration has approved a freeze-dried formulation of its mpox and smallpox vaccine. The company said the newly approved formulation of its vaccine, Jynneos, provides advantages in terms of transportation, storage conditions and shelf life, which are important factors for long-term stockpiling. The...
Carisma Therapeutics Board Approves Revised Operating Plan; Reduces Workforce
Carisma Therapeutics Board Approves Revised Operating Plan; Reduces Workforce
Mar 31, 2025
05:27 PM EDT, 03/31/2025 (MT Newswires) -- Carisma Therapeutics ( CARM ) said late Monday that its board approved a revised operating plan to evaluate alternatives while reducing operational cash burn. The company said it has reduced its workforce, retaining only those deemed essential to pursue strategic alternatives. It has cut operations to core functions necessary to support the strategic...
Copyright 2023-2026 - www.financetom.com All Rights Reserved